Biosimilars: The New Era of Gastroenterology Management Considerations

Part 1: Fundamentals

Part 1: FundamentalsKenneth McQuaid, MD
UCSF School of Medicine

Edward Li, PharmD, MPH, BCOP
University of New England College of Pharmacy

Cathleen Shellnutt, MSN, RN, AGCNS-BC, CGRN
Medical City Plano

Play

Part 2: Biosimilars and Patients with Inflammatory Bowel Disease

Part 2: Biosimilars and Patients with Inflammatory Bowel DiseaseKenneth McQuaid, MD
UCSF School of Medicine

Edward Li, PharmD, MPH, BCOP
University of New England College of Pharmacy

Catherine Bauer, MSN, RN, MBA, CGRN, CFER
University of Virginia Medical Center

Play

New & Noteworthy